Thousand Oaks-based Amgen has signed on to be a part of the Beacon of Hope, a 10-year commitment to co-create programs that address health and education inequities and create greater diversity, equity, inclusion and trust across the research and development ecosystem. The program was created by Novartis and the Novartis US Foundation, which announced the…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
